Hernia Mesh Recall History — What the FDA Found

Key FDA Recalls and Safety Communications

The Composix Kugel Mesh Patch recall (2005-2007) was the first major hernia mesh recall, issued after reports of memory recoil ring failure causing intestinal perforations and fistulas. The FDA classified multiple Kugel recall actions as Class I — the most serious classification, indicating that use of the product may cause serious injury or death. Approximately 100,000 to 200,000 units were recalled across multiple lot numbers over the two-year recall period.

In October 2008, the FDA issued a Public Health Notification warning that it had received over 1,000 adverse event reports from nine manufacturers of surgical mesh used for hernia repair over a three-year period. Complications reported included mesh erosion, infection, pain, and recurrence. The FDA advised surgeons and patients to carefully weigh risks and benefits and to discuss mesh type options before surgery.

In 2016, the FDA issued 522 post-market surveillance study orders to hernia mesh manufacturers requiring them to conduct rigorous clinical studies examining long-term complication rates, particularly mesh shrinkage and chronic pain. The 522 orders acknowledge the FDA's concerns that pre-market data submitted through the 510(k) clearance process was insufficient to characterize long-term mesh performance. The 510(k) clearance pathway — which cleared most hernia mesh by demonstrating substantial equivalence to older devices rather than through independent clinical trials — is itself the subject of criticism in the litigation.

What the Recall History Means for Legal Claims

The documented FDA recall history and safety communications are significant in litigation because they demonstrate that the regulatory agency — and by extension the manufacturers who reported adverse events that triggered these actions — had knowledge of mesh complication patterns. This regulatory record supports plaintiff theories that manufacturers had sufficient notice to revise product warnings, update labeling, or alter mesh design, and that their failure to do so constitutes actionable negligence, design defect, or fraud.